HNSCC

Personalizing Treatment for Head and Neck Cancer Patients

This month is Head and Neck Squamous Cell Carcinoma (HNSCC) Awareness Month. There have been many developments in HNSCC, including a better understanding of its causes, as well as advances in efforts…

Clinical Trial for Patients with the KRAS-variant and HNSCC

Here on MiraKind.org, we’ve already discussed how the KRAS-variant plays a role in breast cancer risk, ovarian cancer risk, effects of MHT in the KRAS-variant patients, and even autoimmunity! Now, we want…

about MiraKind

MiraKind is a 501(c)(3) non-profit organization in Los Angeles, CA.
All donations are tax-deductible.
EIN 46-4451492.

education

testing information

research

our research

studies

hormones, the KRAS-variant and breast cancer risk study

publications

get involved

subscribe to our newsletter

Subscribe Now

socials

Disclaimer: Any discussion of medical management options on this website is for general informational purposes only and does not constitute a medical recommendation. All medical management decisions should be made based on consultation between each patient and his or her healthcare professional.